Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.125 USD | -1.32% | +3.10% | +29.92% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.92% | 134M | |
+8.21% | 115B | |
+12.94% | 107B | |
-13.61% | 22.31B | |
-3.99% | 21.6B | |
-5.79% | 18.23B | |
-39.93% | 17.62B | |
+7.30% | 14.26B | |
+33.59% | 12.37B | |
-28.05% | 8.28B |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- Morgan Stanley Adjusts Price Target on Karyopharm Therapeutics to $7 From $10, Maintains Equalweight Rating